Adrenocortical changes associated with methylandrostenediol-induced hypertension and isoproterenol-induced myocardial infarction in arteriosclerotic versus nonarteriosclerotic rats.
D000311:Adrenal Glands / Q000378:metabolism / Q000473:pathology*; D045930:Anabolic Agents; D000818:Animals; D001011:Aorta / Q000473:pathology; D001161:Arteriosclerosis / Q000473:pathology*; D002784:Cholesterol / Q000097:blood; D003345:Corticosterone / Q000097:blood; D005260:Female; D006322:Heart Aneurysm / Q000209:etiology; D006973:Hypertension / Q000139:chemically induced / Q000473:pathology*; D007545:Isoproterenol; D008297:Male; D009203:Myocardial Infarction / Q000139:chemically induced / Q000150:complications / Q000473:pathology*; D009392:Nephrectomy; D009929:Organ Size; D051381:Rats; D014280:Triglycerides / Q000097:blood
D045930:Anabolic Agents; D014280:Triglycerides; D002784:Cholesterol; D007545:Isoproterenol; D003345:Corticosterone